No Data
Tempest Therapeutics(TPST.US) Officer Buys US$9,951.36 in Common Stock
$Tempest Therapeutics(TPST.US)$ Officer Whiting Samuel purchased 4,672 shares of common stock on Jul 2, 2024 at an average price of $2.13 for a total value of $9,951.36.Source: Announcement What is st
Tempest Therapeutics(TPST.US) Officer Buys US$16,200 in Common Stock
$Tempest Therapeutics(TPST.US)$ Officer Trojanowski Justin purchased 7,500 shares of common stock on Jun 28, 2024 at an average price of $2.16 for a total value of $16,200.Source: Announcement What is
Tempest and SnapSea Announce Strategic Partnership
Collaboration to enhance destination marketing, boost engagement and drive visitation with advanced user-generated content solutions PHILADELPHIA,, July 1, 2024 /PRNewswire/ -- Tempest, a leader in w
Tempest Launches Sports Tourism Index 2.0
Brand new platform introduces exciting new benefits and capabilities for destination organizations and sports events rights holders, alongside sweeping enhancements to existing features PHILADELPHIA,
Tempest Therapeutics Price Target Maintained With a $8.00/Share by Piper Sandler
Tempest Therapeutics Price Target Maintained With a $8.00/Share by Piper Sandler
Piper Sandler Reiterates Overweight on Tempest Therapeutics, Maintains $8 Price Target
Piper Sandler analyst Edward Tenthoff reiterates Tempest Therapeutics with a Overweight and maintains $8 price target.